LYMPHOMA COALITION

Happening Now: The CDDF Workshop 2025, taking place 17–18 November in Brussels and online!

Hosted by the Cancer Drug Development Forum (CDDF), this workshop brings together scientific, clinical, regulatory, and patient leaders to advance smarter clinical trials and strengthen the use of real-world evidence in cancer care.

Natacha Bolaños, Head of Membership & Alliance at Lymphoma Coalition, will present:

🎤 From Patient Experience to HTA Evidence: The MyLymphoma Model for Real-World Data Generation

🕘 18 November, 10:45–11:00 AM

LC is proud to contribute to these important discussions and to advocate for patient-centred evidence that informs innovation in cancer care.

To learn more about the CDDF visit: cddf.org/

#LymphomaCoalition #CDDF2025 #ClinicalTrials #RealWorldEvidence #PatientCentredCare #Lymphoma ... See MoreSee Less

Lymphoma Coalition is participating in the HNHCP Educational Conference 2025 – The 9th HNHCP Educational Conference – in Zurich, Switzerland.

The conference brings together nurses and healthcare professionals from across Europe to exchange insights and strengthen education and collaboration in lymphoma and CLL care. Lymphoma Coalition is engaging in discussions that support improved patient outcomes and highlight the importance of multidisciplinary cooperation in haematology nursing.

LC is pleased to be attending alongside Member, lymphome.ch patientennetz schweiz to further shared goals in patient advocacy, education, and support.

Pictured (L–R): Rosmarie Pfau, President of the Swiss Lymphoma Patient Organization, and Kathryn Perry, Head of Communications and Information, Lymphoma Coalition.

#lymsm #hnhcp2025 #lymphoma #nursingeducation #PatientCare #collaboration ... See MoreSee Less

To mark its 10th anniversary, the Spanish Biosimilars Association (Biosim) celebrated a decade of collaboration to expand access to biologic treatments, recognising the contributions of health system leaders, healthcare professionals, and patient organisations.

The event highlighted the importance of integrating biosimilars into Spain’s National Health System to free up resources for innovation and enhance patient care.

Lymphoma Coalition is deeply honoured to be acknowledged for its role in strengthening biosimilar adoption and promoting equitable access to treatment. Over the past decade, LC has helped improve patient information, support acceptance and appropriate use of biosimilars, and champion shared decision-making to ensure patients’ voices are heard.

📸 Pictured (L–R): Encarna Cruz, General Director of Biosim; Natacha Bolanos, Head of Membership & Alliances at Lymphoma Coalition; and Joaquin Rodrigo, President of Biosim ... See MoreSee Less

🌍 Global Biosimilars Week 2025
📅 November 3–7, 2025
🔖 Theme: “A Wise Investment for Global Health”

Join the 6th annual #GlobalBiosimilarsWeek — a global campaign dedicated to raising awareness of the powerful impact of biosimilar medicines.

💡 Understanding Biosimilars
Biologics are complex medicines derived from living organisms. Their intricate manufacturing processes have traditionally limited access, especially in low- and middle-income regions.
Biosimilars are highly similar versions of biologic medicines, developed through comprehensive analytical, preclinical, and clinical studies to ensure therapeutic equivalence. They offer equally effective and safe alternatives—helping increase market competition and reduce the cost of biologic therapies by up to 60%.
By offering significant cost savings, biosimilars expand access to essential treatments and support more sustainable healthcare systems.

This year’s theme highlights how access to cost-effective biosimilar medicines represents a strategic choice for sustainable healthcare and equitable patient access.

📲 Download campaign materials and the social media toolkit at globalbiosimilarsweek.org

💬 Share your perspectives, stories, and resources using #GlobalBiosimilarsWeek

Let’s work together to make biosimilars a wise investment for global health.
#GlobalBiosimilarsWeek ... See MoreSee Less